These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28389767)

  • 1. A new POT1 germline mutation-expanding the spectrum of POT1-associated cancers.
    Wilson TL; Hattangady N; Lerario AM; Williams C; Koeppe E; Quinonez S; Osborne J; Cha KB; Else T
    Fam Cancer; 2017 Oct; 16(4):561-566. PubMed ID: 28389767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma.
    Wong K; Robles-Espinoza CD; Rodriguez D; Rudat SS; Puig S; Potrony M; Wong CC; Hewinson J; Aguilera P; Puig-Butille JA; Bressac-de Paillerets B; Zattara H; van der Weyden L; Fletcher CDM; Brenn T; Arends MJ; Quesada V; Newton-Bishop JA; Lopez-Otin C; Bishop DT; Harms PW; Johnson TM; Durham AB; Lombard DB; Adams DJ
    JAMA Dermatol; 2019 May; 155(5):604-609. PubMed ID: 30586141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic features of melanoma associated with germline mutations of CDKN2A, CDK4, and POT1 in melanoma-prone families from the United States, Italy, and Spain.
    Sargen MR; Calista D; Elder DE; Massi D; Chu EY; Potrony M; Pfeiffer RM; Carrera C; Aguilera P; Alos L; Puig S; Elenitsas R; Yang XR; Tucker MA; Landi MT; Goldstein AM
    J Am Acad Dermatol; 2020 Sep; 83(3):860-869. PubMed ID: 32283231
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Shen E; Xiu J; Lopez GY; Bentley R; Jalali A; Heimberger AB; Bainbridge MN; Bondy ML; Walsh KM
    J Med Genet; 2020 Oct; 57(10):664-670. PubMed ID: 31937561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.
    Potrony M; Puig-Butille JA; Ribera-Sola M; Iyer V; Robles-Espinoza CD; Aguilera P; Carrera C; Malvehy J; Badenas C; Landi MT; Adams DJ; Puig S
    Br J Dermatol; 2019 Jul; 181(1):105-113. PubMed ID: 30451293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.
    Aoude LG; Pritchard AL; Robles-Espinoza CD; Wadt K; Harland M; Choi J; Gartside M; Quesada V; Johansson P; Palmer JM; Ramsay AJ; Zhang X; Jones K; Symmons J; Holland EA; Schmid H; Bonazzi V; Woods S; Dutton-Regester K; Stark MS; Snowden H; van Doorn R; Montgomery GW; Martin NG; Keane TM; López-Otín C; Gerdes AM; Olsson H; Ingvar C; Borg A; Gruis NA; Trent JM; Jönsson G; Bishop DT; Mann GJ; Newton-Bishop JA; Brown KM; Adams DJ; Hayward NK
    J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25505254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere-lengthening germline variants predispose to a syndromic papillary thyroid cancer subtype.
    DeBoy EA; Nicosia AM; Liyanarachchi S; Iyer SS; Shah MH; Ringel MD; Brock P; Armanios M
    Am J Hum Genet; 2024 Jun; 111(6):1114-1124. PubMed ID: 38688277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline
    Andreotti V; Vanni I; Pastorino L; Ghiorzo P; Bruno W
    Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38254993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
    Shi J; Yang XR; Ballew B; Rotunno M; Calista D; Fargnoli MC; Ghiorzo P; Bressac-de Paillerets B; Nagore E; Avril MF; Caporaso NE; McMaster ML; Cullen M; Wang Z; Zhang X; ; ; ; Bruno W; Pastorino L; Queirolo P; Banuls-Roca J; Garcia-Casado Z; Vaysse A; Mohamdi H; Riazalhosseini Y; Foglio M; Jouenne F; Hua X; Hyland PL; Yin J; Vallabhaneni H; Chai W; Minghetti P; Pellegrini C; Ravichandran S; Eggermont A; Lathrop M; Peris K; Scarra GB; Landi G; Savage SA; Sampson JN; He J; Yeager M; Goldin LR; Demenais F; Chanock SJ; Tucker MA; Goldstein AM; Liu Y; Landi MT
    Nat Genet; 2014 May; 46(5):482-6. PubMed ID: 24686846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A
    Abu Shtaya A; Kedar I; Bazak L; Basel-Salmon L; Barhom SF; Naftali M; Eskin-Schwartz M; Birk OS; Polager-Modan S; Keidar N; Reznick Levi G; Levi Z; Yablonski-Peretz T; Mahamid A; Segol O; Matar R; Bareli Y; Azoulay N; Goldberg Y
    Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. POT1 tumour predisposition: a broader spectrum of associated malignancies and proposal for additional screening program.
    Baptista Freitas M; Desmyter L; Badoer C; Smits G; Vandernoot I; T Kint de Roodenbeke D
    Eur J Hum Genet; 2024 Aug; 32(8):980-986. PubMed ID: 38839987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. POT1 loss-of-function variants predispose to familial melanoma.
    Robles-Espinoza CD; Harland M; Ramsay AJ; Aoude LG; Quesada V; Ding Z; Pooley KA; Pritchard AL; Tiffen JC; Petljak M; Palmer JM; Symmons J; Johansson P; Stark MS; Gartside MG; Snowden H; Montgomery GW; Martin NG; Liu JZ; Choi J; Makowski M; Brown KM; Dunning AM; Keane TM; López-Otín C; Gruis NA; Hayward NK; Bishop DT; Newton-Bishop JA; Adams DJ
    Nat Genet; 2014 May; 46(5):478-481. PubMed ID: 24686849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Cancer-Predisposing Germline
    Jajosky AN; Mitchell AL; Akgul M; Shetty S; Yoest JM; Gerson SL; Sadri N; Oduro KA
    Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline mutations in shelterin complex genes are associated with familial glioma.
    Bainbridge MN; Armstrong GN; Gramatges MM; Bertuch AA; Jhangiani SN; Doddapaneni H; Lewis L; Tombrello J; Tsavachidis S; Liu Y; Jalali A; Plon SE; Lau CC; Parsons DW; Claus EB; Barnholtz-Sloan J; Il'yasova D; Schildkraut J; Ali-Osman F; Sadetzki S; Johansen C; Houlston RS; Jenkins RB; Lachance D; Olson SH; Bernstein JL; Merrell RT; Wrensch MR; Walsh KM; Davis FG; Lai R; Shete S; Aldape K; Amos CI; Thompson PA; Muzny DM; Gibbs RA; Melin BS; Bondy ML;
    J Natl Cancer Inst; 2015 Jan; 107(1):384. PubMed ID: 25482530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of POT1 tumor predisposition syndrome: Tumor prevalence in a clinically diverse hereditary cancer cohort.
    Herrera-Mullar J; Fulk K; Brannan T; Yussuf A; Polfus L; Richardson ME; Horton C
    Genet Med; 2023 Nov; 25(11):100937. PubMed ID: 37466057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based analysis of
    Simonin-Wilmer I; Ossio R; Leddin EM; Harland M; Pooley KA; Martil de la Garza MG; Obolenski S; Hewinson J; Wong CC; Iyer V; Taylor JC; Newton-Bishop JA; Bishop DT; Cisneros GA; Iles MM; Adams DJ; Robles-Espinoza CD
    J Med Genet; 2023 Jul; 60(7):692-696. PubMed ID: 36539277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline mutations predisposing to melanoma.
    Toussi A; Mans N; Welborn J; Kiuru M
    J Cutan Pathol; 2020 Jul; 47(7):606-616. PubMed ID: 32249949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer.
    Orois A; Badenas C; Reverter JL; López V; Potrony M; Mora M; Halperin I; Oriola J
    Horm Cancer; 2020 Apr; 11(2):111-116. PubMed ID: 32172474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline POT1 Deregulation Can Predispose to Myeloid Malignancies in Childhood.
    Michler P; Schedel A; Witschas M; Friedrich UA; Wagener R; Mehtonen J; Brozou T; Menzel M; Walter C; Nabi D; Pearce G; Erlacher M; Göhring G; Dugas M; Heinäniemi M; Borkhardt A; Stölzel F; Hauer J; Auer F
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769003
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Maas EJ; DeBortoli E; Nathan V; Freeman NP; Mothershaw A; Smit DJ; Betz-Stablein B; Aoude LG; Stark MS; Sturm RA; Soyer HP; McInerney-Leo AM
    J Med Genet; 2024 Aug; 61(9):891-894. PubMed ID: 38724174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.